iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography - Seite 3

Contacts:
Media inquiries:
Jessica Burns, iCAD  
[phone]
[e-mail]

Investor Relations:
Jeremy Feffer, LifeSci Advisors
[phone]
[e-mail]

____________________________

¹ *iCAD data on file. Standalone performance varies by vendor. FDA Cleared.
² Conant, E et al. (2019). Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiology: Artificial Intelligence. 1 (4). Accessed via https://pubs.rsna.org/doi/10.1148/ryai.2019180096
³ Eriksson M, Czene K, Strand F, et al. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening. [published online ahead of print September 8, 2020]. Radiology. Accessed via https://doi.org/10.1148/radiol.2020201620